The Urologic Oncology Program provides highly specialized care for patients with tumors of the genitourinary (GU) tract. Our physicians have specialized clinical and research interest in tumors of the prostate, testis, kidney, and bladder. Our group of urologic oncologists, medical oncologists, radiation oncologists, advanced practice nurses, nurse navigators, and clinicians combine their expertise and experience to create the best care plan for their patients.
Rutgers Cancer Institute of New Jersey is a leader in laparoscopic renal procedures and has extensive experience with robotic prostatectomy. The major advantages of robotic prostatectomy include shorter hospital stays, lower blood loss, and faster recovery. Given that robotic surgery is a relatively new technology, surgeon experience is critical for good outcome. Rutgers Cancer Institute has developed a center of excellence for robotic surgery. Our urologic oncologists have performed more than 1,500 robotic prostatectomies over the last five years.
The Urologic Oncology Program offers a wide breadth of clinical trials for patients with tumors of the genitourinary tract. In addition, the Prostate Cancer Program provides a hub for basic and clinical research in prostate cancer as well as a forum for prostate cancer outreach activities.
Clinical Trials:
Thomas L. Jang, MD, MPH, FACS, Director of the Testicular Cancer Program; Director, Safety and Outcomes for the Division of Urology; Director of Clinical Operations, Urologic Oncology and Associate Chief of Urologic Oncology
Eric A. Singer, MD, MA, MS, FACS, FASCO, Director of Academic Affairs and Faculty Development, Urologic Oncology, Associate Chief of Urology and Director, Kidney Cancer Program
Medical Oncologists
Wadih Arap, MD, PhD, Director, Rutgers Cancer Institute of New Jersey at University Hospital
Tina Mayer, MD 
Biren Saraiya, MD
Ryan D. Stephenson, DO
Urologic Oncologists
Eric A. Singer, MD, MA, MS, FACS, FASCO, Director of Academic Affairs and Faculty Development, Urologic Oncology, Associate Chief of Urology and Director, Kidney Cancer ProgramThomas L. Jang, MD, MPH, FACS, Director of the Testicular Cancer Program; Director, Safety and Outcomes for the Division of Urology; Director of Clinical Operations, Urologic Oncology and Associate Chief of Urologic Oncology
Saum Ghodoussipour, MD, Director of the Bladder and Urothelial Cancer Program
Radiation Oncologists
Ronald D. Ennis, MD, Medical Director, Clinical Network for Radiation Oncology
Lara Hathout, MD, FRCPC, Director of Brachytherapy, Department of Radiation Oncology
Rahul R. Parikh, MD, Medical Director, Laurie Proton Therapy Center
Advanced Practice Providers
Nurses and Technician
